267 related articles for article (PubMed ID: 32886342)
1. A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT
Echeverry C; Prunell G; Narbondo C; de Medina VS; Nadal X; Reyes-Parada M; Scorza C
Neurotox Res; 2021 Apr; 39(2):335-348. PubMed ID: 32886342
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
3. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.
Sartim AG; Guimarães FS; Joca SR
Behav Brain Res; 2016 Apr; 303():218-27. PubMed ID: 26801828
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews.
Rock EM; Sullivan MT; Collins SA; Goodman H; Limebeer CL; Mechoulam R; Parker LA
Psychopharmacology (Berl); 2020 Sep; 237(9):2621-2631. PubMed ID: 32488349
[TBL] [Abstract][Full Text] [Related]
6. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
[TBL] [Abstract][Full Text] [Related]
7. Phytochemical Characterization and TRPA1/TRPM8 Modulation Profile of the Cannabigerol-Rich
Gargiulo E; Moriello AS; Benetti E; Pagni L; Arnoldi L; De Petrocellis L; Chianese G; Vitale RM; Taglialatela-Scafati O
J Nat Prod; 2024 Apr; 87(4):722-732. PubMed ID: 38408345
[TBL] [Abstract][Full Text] [Related]
8. Effect of prior foot shock stress and Δ
Rock EM; Limebeer CL; Petrie GN; Williams LA; Mechoulam R; Parker LA
Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834
[TBL] [Abstract][Full Text] [Related]
9. Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets.
Fellous T; De Maio F; Kalkan H; Carannante B; Boccella S; Petrosino S; Maione S; Di Marzo V; Iannotti FA
Biochem Pharmacol; 2020 May; 175():113859. PubMed ID: 32061773
[TBL] [Abstract][Full Text] [Related]
10. Effect of combined doses of Δ
Rock EM; Sullivan MT; Pravato S; Pratt M; Limebeer CL; Parker LA
Psychopharmacology (Berl); 2020 Mar; 237(3):901-914. PubMed ID: 31897571
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice.
Burgaz S; García C; Gómez-Cañas M; Navarrete C; García-Martín A; Rolland A; Del Río C; Casarejos MJ; Muñoz E; Gonzalo-Consuegra C; Muñoz E; Fernández-Ruiz J
Mol Cell Neurosci; 2021 Jan; 110():103583. PubMed ID: 33338634
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.
Chaves YC; Genaro K; Crippa JA; da Cunha JM; Zanoveli JM
Metab Brain Dis; 2021 Apr; 36(4):639-652. PubMed ID: 33464458
[TBL] [Abstract][Full Text] [Related]
13. Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews.
Rock EM; Goodwin JM; Limebeer CL; Breuer A; Pertwee RG; Mechoulam R; Parker LA
Psychopharmacology (Berl); 2011 Jun; 215(3):505-12. PubMed ID: 21243485
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol.
Smeriglio A; Giofrè SV; Galati EM; Monforte MT; Cicero N; D'Angelo V; Grassi G; Circosta C
Fitoterapia; 2018 Jun; 127():101-108. PubMed ID: 29427593
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.
Pazos MR; Mohammed N; Lafuente H; Santos M; Martínez-Pinilla E; Moreno E; Valdizan E; Romero J; Pazos A; Franco R; Hillard CJ; Alvarez FJ; Martínez-Orgado J
Neuropharmacology; 2013 Aug; 71():282-91. PubMed ID: 23587650
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes.
di Giacomo V; Chiavaroli A; Recinella L; Orlando G; Cataldi A; Rapino M; Di Valerio V; Ronci M; Leone S; Brunetti L; Menghini L; Zengin G; Ak G; Abdallah HH; Ferrante C
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443623
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors.
Rodrigues da Silva N; Gomes FV; Sonego AB; Silva NRD; Guimarães FS
Pharmacol Res; 2020 Jun; 156():104749. PubMed ID: 32151683
[TBL] [Abstract][Full Text] [Related]
18. Raman-Based Differentiation of Hemp, Cannabidiol-Rich Hemp, and Cannabis.
Sanchez L; Baltensperger D; Kurouski D
Anal Chem; 2020 Jun; 92(11):7733-7737. PubMed ID: 32401504
[TBL] [Abstract][Full Text] [Related]
19. Phytocannabinoids CBD, CBG, and their Derivatives CBD-HQ and CBG-A Induced In Vitro Cytotoxicity in 2D and 3D Colon Cancer Cell Models.
Bęben D; Siwiela O; Szyjka A; Graczyk M; Rzepka D; Barg E; Moreira H
Curr Issues Mol Biol; 2024 Apr; 46(4):3626-3639. PubMed ID: 38666957
[TBL] [Abstract][Full Text] [Related]
20. Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation.
Amstutz K; Schwark WS; Zakharov A; Gomez B; Lyubimov A; Ellis K; Venator KP; Wakshlag JJ
J Vet Pharmacol Ther; 2022 May; 45(3):245-254. PubMed ID: 35246858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
